Japan on Thursday suspended the use of 1.63 million doses shipped to 863 vaccination centres nationwide, more than a week after the domestic distributor, Takeda Pharmaceutical, received reports of contaminants in some vials
The dollar index, which measures the currency against six rivals, edged up 0.05% to 92.867 after dropping to 92.801 overnight for the first time since Aug. 17
Decision comes after announcement that Pakistan is set to receive 2.5 million doses of the vaccine through the UN-backed Covax global vaccine sharing programme
Vaccine can be administered to people suffering from diabetes, hypertension, and other diseases
Moderna will increase its deliveries to 1.33 million doses a week in July from 733,000 previously expected, raising the figure to 2.57 million a week in August and 2.95 million a week in September, the ministry said.
Swiss Health Minister Alain Berset said about 15 of the staff identified by the government for the Lonza assignment in Visp could start this month.
"We started a programme immediately to find specialists," Berset told a news conference in Bern. "We've found 75 people in the federal administration, also in the universities."
Moderna said an initial analysis of a study in adolescents aged 12-17 years showed an efficacy rate of 96% for its vaccine.
The company has also been working on a new version that could extend the time the vaccine can be stored in refrigerator temperatures, making it easier to distribute, especially in lower-income countries.
The risk of infection fell 90% by two weeks after the second shot, the study of just under 4,000 vaccinated U.S. healthcare personnel and first responders found.
The trial, backed by the National Institutes of Health (NIH), is designed to determine if the vaccine, mRNA-1273, can prevent coronavirus infection, limit virus in the nose, and reduce transmission from vaccinated individuals to their close contacts.
The Prevent COVID U study, funded by the National Institute of Allergy and Infectious Diseases (NIAID), will monitor about 12,000 young adults across 20 universities over a five-month period.
The planned March deliveries exceed initial expectations, and Kronig said they'll be sufficient to make up for slightly lower volumes that arrived last month.
New infections reported on Tuesday totaled 1,378 cases, well below the 10,000-plus record from Nov. 2. Another 13 deaths were reported.
Moderna's two-shot vaccine is one of the three COVID-19 vaccines authorized for emergency use in the United States along with Pfizer/BioNTech and Johnson & Johnson's.
Under the pact with Baxter, the fill and finish of Moderna COVID-19 vaccine will take place at the sterile manufacturing facilities located in Bloomington, Indiana, the companies said.
Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.
Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.